FDA OKs AtriCure disposable cryoablation system for arrhythmias

Twitter icon
Facebook icon
LinkedIn icon
e-mail icon
Google icon
AtriCure has received 510(k) clearance from the FDA for Cryo1, its disposable cryoablation system for the treatment of cardiac arrhythmias.

The West Chester, Ohio-based company said its Cryo1 system has a long, malleable, yet rigid, design to achieve thermal dynamics and an active defrost mode. Also, the AtriCure Frigitronics CCS-200 console supports both its Cryo1 disposable probe and its line of reusable cryoablation probes.